“Evaluation of inflammatory and biochemical markers in COVID-19 patients treated with tocilizumab alone or with the combination of tocilizumab and convalescent plasma transfusion”, Ann Med Res , vol. 29, no. 7, pp. 770–776, Jul. 2022, Accessed: Apr. 07, 2025. [Online]. Available: http://annalsmedres.org/index.php/aomr/article/view/4231